Vertex Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel)

 - Results from CLIMB-111, -121 and -131 accepted for oral presentation -

- Data from these trials, with the longest follow-up of more than five years, demonstrate transformative, consistent and durable benefit of CASGEVY™ -

- Safety profile consistent with busulfan conditioning and autologous hematopoietic stem cell transplant -

https://www.businesswire.com/news/home/20240613723433/en